1. Faculty of Sexual and Reproductive Healthcare (FSRH) - Clinical Effectiveness Unit Clinical guidance: Drug interactions with hormonal contraception - January 2011 (Updated 2012) http://www.fsrh.org/pdfs/CEUguidancedruginteractionshormonal.pdf
2. Bayer Summary of product characteristics: YAZ 0.02 mg/3 mg film coated tablets. 2015 http://www.medicines.ie/medicine/13973/SPC/Yaz+0.02mg+++3mg+film+coated+tablets
3. US Food and Drug Administration Center for Drug Evaluation and Research: NDA 202-258 - Secondary clinical pharmacology review 2011 http://www.accessdata.fda.gov/drugsatfda_docs/nda/2011/202258orig1s000clinpharmr.pdf
4. General framework for the quantitative prediction of CYP3A4-mediated oral drug interactions based on the AUC increase by coadministration of standard drugs;Ohno;Clin Pharmacokinet,2007